BPG is committed to discovery and dissemination of knowledge
Featured Articles
5/24/2022 1:34:23 PM | Browse: 198 | Download: 568
Publication Name World Journal of Clinical Oncology
Manuscript ID 74102
Country/Territory United States
Received
2021-12-25 23:41
Peer-Review Started
2021-12-25 23:42
To Make the First Decision
Return for Revision
2022-03-16 08:47
Revised
2022-03-29 09:28
Second Decision
2022-04-12 01:58
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-04-21 19:19
Articles in Press
2022-04-21 19:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-05-18 08:56
Publish the Manuscript Online
2022-05-24 12:41
ISSN 2218-4333 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Survival Characteristics of Fibrolamellar Hepatocellular Carcinoma: A SEER Database Study
Manuscript Source Invited Manuscript
All Author List Tomoki Sempokuya, Arnold Forlemu, Muaataz Azawi, Krixie Silangcruz, Nathalie Khoury, Jihyun Ma and Linda L Wong
Funding Agency and Grant Number
Funding Agency Grant Number
None
Corresponding Author Tomoki Sempokuya, MD, Doctor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Nebraska Medical Center, 982000 Nebraska Medical Center, Omaha, NE 68198, United States. , Omaha, NE 68198, United States. tsempoku@hawaii.edu
Key Words Fibrolamellar hepatocellular carcinoma; transplant; race; age; survival
Core Tip Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare and distinct type of hepatocellular carcinoma. Currently, there is limited data on survival associated with FL-HCC. This retrospective study based on the SEER database suggests a better survival of younger patients with FL-HCC, although they had aggressive diseases. This trend may be because they received more surgical interventions. There were no racial differences in survival for FL-HCC, which is seen in HCC. The patient who had wedge or segmental resection or lobectomy had better survival.
Publish Date 2022-05-24 12:41
Citation Sempokuya T, Forlemu A, Azawi M, Silangcruz K, Khoury N, Ma J, Wong LL. Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study. World J Clin Oncol 2022; 13(5): 352-365
URL https://www.wjgnet.com/2218-4333/full/v13/i5/352.htm
DOI https://dx.doi.org/10.5306/wjco.v13.i5.352
Full Article (PDF) WJCO-13-352.pdf
Full Article (Word) WJCO-13-352.docx
Manuscript File 74102_Auto_Edited.docx
Answering Reviewers 74102-Answering reviewers.pdf
Audio Core Tip 74102-Audio core tip.m4a
Biostatistics Review Certificate 74102-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 74102-Conflict-of-interest statement.pdf
Copyright License Agreement 74102-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 74102-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 74102-Institutional review board statement.pdf
Peer-review Report 74102-Peer-review(s).pdf
Scientific Editor Work List 74102-Scientific editor work list.pdf